Related Content
September 5, 2019 — Abbott announced the launch of the company's TRILUMINATE Pivotal trial evaluating the safety and ...
New technologies have been developed that may replace the traditional pressure wires and adenosine to assess the ...
August 5, 2019 — Abbott is recalling the Ellipse Implantable Cardioverter Defibrillators (ICDs) because electrical ...
July 17, 2019 — Abbott has received U.S. Food and Drug Administration (FDA) approval for the most advanced MitraClip ...
June 11, 2019 — Abbott recently announced positive late-breaking data from its TRILUMINATE study of the company's ...
This is a brief overview of updates on implantable cardioverter defibrillators (ICD), including new technology ...
May 14, 2019 – The first prospective, multicenter, randomized, controlled trial to compare conventional pulmonary vein ...
March 25, 2019 — Patients who stopped taking aspirin one month after receiving a stent in the heart’s arteries but ...
March 22, 2019 — Severely ill patients with advanced heart failure who received the HeartMate 3 left ventricular assist ...
March 21, 2019 — Clinicians should use echocardiography when determining whether patients with heart failure and a ...